nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome
|
Hansen, Elizabeth |
|
2016 |
65 |
6 |
p. 765-767 |
artikel |
2 |
Concomitant targeting of programmed death-1 (PD-1) and CD137 improves the efficacy of radiotherapy in a mouse model of human BRAFV600-mutant melanoma
|
Kroon, Paula |
|
2016 |
65 |
6 |
p. 753-763 |
artikel |
3 |
Determining predictive factors for immune checkpoint inhibitor toxicity: Response to Letter to the Editors “A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome”
|
Spain, Lavinia |
|
2016 |
65 |
6 |
p. 769-770 |
artikel |
4 |
Differential immunomodulatory activity of tumor cell death induced by cancer therapeutic toll-like receptor ligands
|
Klein, Johanna C. |
|
2016 |
65 |
6 |
p. 689-700 |
artikel |
5 |
Disease progression in recurrent glioblastoma patients treated with the VEGFR inhibitor axitinib is associated with increased regulatory T cell numbers and T cell exhaustion
|
Four, Stephanie Du |
|
2016 |
65 |
6 |
p. 727-740 |
artikel |
6 |
Endostatin inhibits the growth and migration of 4T1 mouse breast cancer cells by skewing macrophage polarity toward the M1 phenotype
|
Guo, Hua |
|
2016 |
65 |
6 |
p. 677-688 |
artikel |
7 |
Immunogenicity and efficacy of the novel cancer vaccine based on simian adenovirus and MVA vectors alone and in combination with PD-1 mAb in a mouse model of prostate cancer
|
Cappuccini, Federica |
|
2016 |
65 |
6 |
p. 701-713 |
artikel |
8 |
Myeloid-derived suppressor cells correlate with patient outcomes in hepatic arterial infusion chemotherapy for hepatocellular carcinoma
|
Mizukoshi, Eishiro |
|
2016 |
65 |
6 |
p. 715-725 |
artikel |
9 |
Neutrophil elastase enhances antigen presentation by upregulating human leukocyte antigen class I expression on tumor cells
|
Chawla, Akhil |
|
2016 |
65 |
6 |
p. 741-751 |
artikel |
10 |
2′–5′ Oligoadenylate synthetase-like 1 (OASL1) deficiency in mice promotes an effective anti-tumor immune response by enhancing the production of type I interferons
|
Sim, Chan Kyu |
|
2016 |
65 |
6 |
p. 663-675 |
artikel |
11 |
Strategies to genetically engineer T cells for cancer immunotherapy
|
Spear, Timothy T. |
|
2016 |
65 |
6 |
p. 631-649 |
artikel |
12 |
Tumour infiltrating lymphocytes correlate with improved survival in patients with oesophageal adenocarcinoma
|
Noble, Fergus |
|
2016 |
65 |
6 |
p. 651-662 |
artikel |